Login to Your Account



Advent France Biotech raises $70M in first close of new seed fund

By Cormac Sheridan
Staff Writer

Thursday, April 20, 2017

DUBLIN – French biotech has a new source of cash for early stage ventures. Advent France Biotechnology has raised €64.75 million in a first closing of a new seed fund, which has a mandate to back first or best-in-class breakthrough innovations that address unmet medical needs.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription